ABBOTT LABORATORIES — Director's Dealing 2006

Jul 28, 2006

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ABBOTT LABORATORIES (ABT)
CIK: 0000001800
Period of Report: 2006-07-25

Reporting Person: REYNOLDS W ANN (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2006-07-25	Common shares without par value	M	1796	$24.1999	Acquired	38798	Direct
2006-07-25	Common shares without par value	S	1796	$48.00	Disposed	37002	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2006-07-25	Option (right to buy)	$24.1999	M	1796	Disposed	2006-12-30	common shares (1796)	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common shares without par value	1677	Indirect
Common shares without par value	715	Indirect

Footnotes

F1: Includes shares acquired under the Abbott Laboratories Dividend Reinvestment and Stock Purchase Plan. These transactions were exempt from Section 16 under Rule 16a-11.

F2: The reporting person disclaims beneficial ownership of all securities held by her husband.

F3: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16(b) under Rule 16b-3.